In vivo effect of diallyl sulfide and cimetidine on phenacetin metabolism and bioavailability in rat.

• Authors: Mirosław M Szutowski , Katarzyna Zalewska , Marta Jadczak , Monika Marek
• Languages of publication: EN

Abstracts

EN

Numerous cytochrome P450 inhibitors have been described as effective modulators of cytochrome P450 isoforms activity in vitro. Their inhibitory efficiency may be considerably modified after in vivo application. The aim of this study was to examine the effect of oral administration of diallyl sulfide - a cytochrome P450 2E1 inhibitor and cimetidine - a cytochrome P450 2C6 and 2C11 inhibitor on rat serum concentration of phenacetin and its metabolite acetaminophen. Both inhibitors increased area under the curve (AUC04h) for phenacetin by 50%. Only cimetidine reduced AUC04h for acetaminophen indicating inhibition of O-deethylation activity. Quinidine - a cytochrome P450 2D subfamily and P-glycoprotein inhibitor did not change significantly phenacetin bioavailability. These results suggest that diallyl sulfide inhibits the deacetylation pathway catalysed by arylamine N-acetyl transferase. Beside cytochrome P450 1A2 other cytochrome P450 isoforms (2A6 and/or 2C11) are involved in phenacetin O-deethylation in rat.

Keywords

EN

diallyl sulfide; cimetidine; phenacetin

• Publisher: Polish Biochemical Society
• Journal: Acta Biochimica Polonica
• Year: 2002
• Volume: 49
• Issue: 1
• Pages: 249-256

Dates

published

2002

received

2001-09-10

revised

2002-02-07

accepted

2002-03-02

Contributors

author

Mirosław M Szutowski

• Department of Toxicology, The Medical University of Warsaw, Warszawa, Poland

author

Katarzyna Zalewska

• Department of Toxicology, The Medical University of Warsaw, Warszawa, Poland

author

Marta Jadczak

• Department of Toxicology, The Medical University of Warsaw, Warszawa, Poland

author

Monika Marek

• Department of Toxicology, The Medical University of Warsaw, Warszawa, Poland

References

• 1. Hansten, P.D. (1985) Drug Interactions. (Lea, & Febiger, eds.) p. 419, Philadelphia.
• 2. Tassaneeyakul, W., Birkett, D.J. & Veronese, M.E. (1993) Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2. J. Pharmacol. Exp. Ther. 265, 401-407.
• 3. Venkatakrishnan, K., von Moltke, L.L. & Greenblatt, D.J. (1998) Human cytochrome P450 mediating phenacetin Odeethylation in vitro: Validation of the high affinity component as an index of CYP 1A2 activity. J. Pharm. Sci. 87, 1502-1507.
• 4. Yang, T.J., Say, Y., Krausz, K.W., Gonzalez, F.J. & Gelboin, H.V. (1998) Inhibitory monoclonal antibodies to human cytochrome P450 1A2: Analysis of phenacetin O-deethylation in human liver. Pharmacogenetics 8, 375-382.
• 5. Kitada, M., Kamataki, T. & Kitagawa, H. (1978) Enhancement in vivo of drug oxidation following administration of benzphetamine, acetone, metyrapon and dimetylosulfoxide. Jpn. J. Pharmacol. 28, 213-221.
• 6. Sesardic, D., Edwards, R.J., Davies, D.S., Thomas, P.E., Levin, W. & Boobis, A.R. (1990) High affinity phenacetin Odeethylase is catalysed specifically by cytochrome P450 1A2 in the liver of the rat. Biochem. Pharmacol. 39, 489-498.
• 7. Shimada, T., Mimura, M., Inoue, K., Nakamura, S., Oda, H., Ohmari, S. & Yamazaki, H. (1997) Cytochrome P450dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pig, dogs, monkeys and humans. Arch. Toxicol. 71, 401-408.
• 8. Wargovich, M.J. & Goldgberg, M.T. (1985) Diallyl sulfide, a naturally occurring thioether that inhibits carcinogen-induced nuclear damage to colon epithelial cells in vivo . Mutat. Res. 143, 127-129.
• 9. Wargovich, M.J. (1987) Diallyl sulfide, a flavor component of garlic (Allium sativum ), inhibits dimethylhydrazine-induced colon cancer. Carcinogenesis 8, 487-489.
• 10. Hayes, M.A, Rushmore, T.H. & Goldberg, M.T. (1987) Inhibition of hepatocarcinogenic responses to 1,2-dimethylhydrazine by diallyl sulfide, a component of garlic oil. Carcinogenesis 8, 1155-1157.
• 11. Wargovich, M.J, Woods, C., Eng, V.W.S., Stephens, L.C. & Gray, K. (1988) Chemoprevention of N-nitrosomethylbenzylamine-induced esophageal cancer in rats by the naturally occurring thioether, diallyl sulfide. Cancer Res. 48, 6872-6875.
• 12. Dwivedi, C., Rohlfs, S., Jarvis, D. & Engineer, F.N. (1992) Chemoprevention of chemically induced skin tumor development by diallyl sulfide and diallyl disulfide. Pharmaceut. Res. 9, 1668-1670.
• 13. Brady, J.F, Li, D., Ishizaki, H. & Yang, C.S. (1988) Effect of diallyl sulfide on rat liver microsomal nitrosoamine metabolism and other monooxygenase activities. Cancer Res. 48, 5937-5940.
• 14. Yang, C.S,, Yoo, J.-S., Ishizaki, H. & Hong, J.-Y. (1990) Cytochrome P450IIE1: Roles in nitrosamine metabolism and mechanisms of regulation. Drug Metab. Rev. 22, 147-160.
• 15. Brady, J.F, Wang, M.-H., Hong, J.-Y., Xiao, F., Li, Y., Yoo, J.-S.H., Ning, S.M., Lee, M.-J., Fukuto, J.M., Gapac, J.M. & Yang, C.S. (1991) Modulation of rat hepatic microsomal monooxygenase enzymes and cytotoxicity by diallyl sulfide. Toxicol. Appl. Pharm. 108, 342-354.
• 16. Dragnev, K.H., Nims, R.W. & Lubet, R.A. (1995) The chemopreventive agent diallyl sulfide a structurally atypical phenobarbital-type inducer. Biochem. Pharmacol. 50, 2099-2104.
• 17. Haber, D., Siess, M.H., Canivenc-Lavier, M.C., Le Bon, A.M. & Suchetet, M. (1995) Differential effects of dietary diallyl sulfide and diallyl disulfide on rat intestinal and hepatic drug- metabolizing enzymes. J. Toxicol. Env. Health 44, 423-434.
• 18. Guyonnet, D., Siess, M.H., Le Bon, A.M. & Suchetet, M. (1999) Modulation of phase II enzymes by organosulfur compounds from allium vegetables in rat tissues. Toxicol. Appl. Pharm. 154, 50-58.
• 19. Pan, J., Hong, J.-Y., Li, D., Schuetz, E.G., Guzelian, P.S., Huang, W. & Yang, C.S. (1993) Regulation of cytochrome P450 2B1/2 genes by diallyl sulfone, disulfiram, and other organosulfur compounds in primary cultures of rat hepatocytes. Biochem. Pharmacol. 45, 2323-2329.
• 20. Hong, J.Y., Smith, T., Lee, M.-J., Li, W., Ma, B.L., Ning, S.M., Brady, J.F., Thomas, P.E. & Yang, C.S. (1991) Metabolism of carcinogenic nitrosoamines by rat liver nasal mucosa and the effect of diallyl sulfide. Cancer Res. 51, 1509-1514.
• 21. Chang, T., Levine, M., Bandiera, S.M. & Bellward, G.D. (1992) Selective inhibition of rat hepatic microsomal cytochrome P-450. I. Effect of the in vivo administration of cimetidine. J. Pharmacol. Exp. Ther. 260, 1441-1449.
• 22. Chang, T., Levine, M. & Bellward, G.D. (1992) Selective inhibition of rat hepatic microsomal cytochrome P-450. II. Effect of the in vitro administration of cimetidine. J. Pharmacol. Exp. Ther. 260, 1450-1455.
• 23. Levine, M., Law, E.Y.W., Bandiera, S.M., Chang, T.K.H. & Bellward, G.D. (1998) In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats. J. Pharmacol. Exp. Ther. 284, 493-499.
• 24. Su, S.F. & Huang, J.D. (1996) Inhibition of the intestinal digoxin absorption and exsorption by quinidine. Drug Metab. Dispos. 24, 142-147.
• 25. Emi, Y., Tsunashima, D., Ogawara, K., Higaki, K. & Kimura, T. (1998) Role of P-glycoprotein as a secretory mechanism in quinidine absorption from rat small intestine. J. Pharm. Sci. 87, 295-299.
• 26. Collett, A., Higgs, N.B., Sims, E., Rowland, M. & Warhurst, G. (1999) Modulation of the permeability of H2 receptor antagonists cimetidine and ranitidine by P-glycoprotein in rat intestine and the human colonic cell line Caco-2 J. Pharmacol. Exp. Ther. 288, 171-178.
• 27. Chung, J.G. (1999) Effects of garlic components diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in human bladder tumor cells. Drug Chem. Toxicol. 22, 343-358.
• 28. Kudo, S., Umehara, K., Hosokawa, M., Miyamoto, G., Chiba, K. & Satoh, T. (2000) Phenacetin deacetylase activity in human liver microsomes: Distribution, kinetics, and chemical inhibition and stimulation. J. Pharmacol. Exp. Ther. 294, 80-88.
• 29. Chung, J.G., Chen, G.W., Wu, L.T., Lin, J.G., Yeh, C.C. & Wang, T.F. (1998) Effects of garlic compounds diallyl sulfide and diallyl disulfide on arylamine N-acetyltransferase activity in strains of Helicobacter pylori from peptic ulcer patients. Am. J. Chinese Med. 26, 353-364.